| 1 day | -1.13% |
| 3 years | 4.81 |  | 31.5 |
| 5 years | 4.81 | | 64.5 |
| 10 years | 4.81 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Evan Loh
CEO | Chief Executive Officer | 67 | 2025-05-20 |
| Chief Tech/Sci/R&D Officer | - | 2019-12-31 | |
Jonathan Neely
IRC | Investor Relations Contact | - | 2020-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Evan Loh
BRD | Director/Board Member | 67 | 2025-05-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/21/25 | Issuer sale | Chief Financial Officer | 82,491 | 0.8204% | ||
| 5/21/25 | Issuer sale | Director | 12,624 | 0.1255% | ||
| 5/21/25 | Issuer sale | Director | 12,624 | 0.1255% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.13% | -.--% | - | - | 97.22M | |
| -0.11% | +9.94% | +57.20% | +148.21% | 1,255B | |
| -1.62% | -0.95% | +42.90% | +75.88% | 641B | |
| -0.98% | -0.14% | +34.93% | +102.23% | 505B | |
| +0.27% | -2.01% | +48.03% | +64.79% | 381B | |
| -2.49% | +2.01% | +75.38% | +39.94% | 357B | |
| +0.83% | +2.57% | +30.61% | +57.34% | 303B | |
| -0.17% | +7.49% | +9.51% | +33.51% | 286B | |
| -0.90% | +2.97% | +55.67% | +70.93% | 249B | |
| -1.68% | +5.27% | +37.21% | +105.26% | 208B | |
| Average | +0.52% | +2.95% | +43.50% | +77.57% | 465.02B | |
| Weighted average by Cap. | +0.93% | +3.90% | +46.77% | +93.61% |
Employees
128
Sector
Pharmaceuticals
